The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced an expansion of its manufacturing technology center in Norwood, Massachusetts by more than doubling production and lab space.
The...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, reports that it is making new funding commitments to increase supply of its COVID-19 vaccine at its owned and partnered manufacturing facilities to be...
The US government is looking at options to provide US-made doses of AstraZeneca’s COVID-19 vaccine to India and is funding an expansion of manufacturing capacity for Biological E. Limited (BioE), a Hyderabad, India based vaccine and pharmaceutical...
The European Commission is working with Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, on a new contract for their COVID-19 vaccine with the aim to deliver 1.8 billion doses to the European Union (EU) for 2021 to 2023.
“The...
The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have lifted a pause on the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine in the US and recommended that the rollout of the vaccine...
The latest on COVID-19 vaccines/drugs and manufacturing from AstraZeneca, Merck & Co., Gilead Sciences, Dr. Reddy’s, Valneva, Inovio, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
AstraZeneca Responds to EU’s Legal...
Sanofi has entered into an agreement with Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, to provide fill–finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine in...
Pfizer has acquired Amplyx Pharmaceuticals, a San Diego, California-based biopharmaceutical company developing therapies for people with compromised immune systems susceptible to fungal infections. Financial terms were not disclosed.
Amplyx’s lead...
Merck & Co. has announced goals to achieve carbon neutrality across its operations by 2025 and a 30% reduction in its value-chain emissions by 2030.
Merck says it will achieve carbon neutrality by increasing efficiency, reducing carbon...
A roundup of news from China (BeiGene), Denmark (Novo Nordisk), France (Sanofi), Germany (BMS, Evotec, Merck KGaA), and the US (Moderna).
China
BeiGene Gets OK for Commercial Supply Mfg at Biologics Facility BeiGene, a Beijing-based...
The Biden Administration has announced $1.7 billion in funding from the American Rescue Plan to help states and other jurisdictions address COVID-19 variants.
The original strain of COVID-19 comprises only about half of all cases, according to...
The latest on COVID-19 vaccines/drugs and manufacturing from Lilly, GSK, Moderna, Fujifilm, Novavax, CureVac, the Serum Institute of India, Bharat Biotech, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
Serum Institute of...
Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, have announced they will supply an additional 100 million doses of their COVID-19 vaccine to the 27 European Union (EU) member states in 2021.
This announcement is a result of the...
Johnson & Johnson (J&J) has provided updates on the manufacturing of its COVID-19 vaccine as well as on its rollout in the US and Europe.
On the manufacturing front, J&J reported that it is working closely with the US...
Vertex Pharmaceuticals and CRISPR Therapeutics, a Swiss-US-based company developing therapeutics based on CRISPR-Cas9 gene-editing technology, have formed a $1.1-billion pact to develop, manufacture, and commercialize CRISPR Therapeutics’ CTX001,...
